Showing results (241-250 of 279) with videos related to

Sort By:
Pageof 28
Seminars in Oncology|April 16, 1998
Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancerU Gatzemeier, C Manegold, W Eberhard, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1997
[CT angiography of the pulmonary artery in patients with bronchial carcinoma]F Stöblen, K Neumann, W Eberhardt, et al.
Journal of Cancer Research and Clinical Oncology|October 21, 2006
Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cellsPeter Ebeling, P Bach, U Sorg, et al.
British Journal of Haematology|March 1, 1993
Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemiaO Kloke, N Niederle, J Y Qiu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib studyB Schultheis, G Folprecht, J Kuhlmann, et al.
British Journal of Haematology|August 1, 1992
Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemiaU B Wandl, O Kloke, M Nagel-Hiemke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trialC Pöttgen, W Eberhardt, S Bildat, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: first clinical dataT Moritz, O Kloke, M Nagel-Hiemke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancerH Wilke, U Klaassen, W Achterrath, et al.
Biochemistry|February 15, 2001
Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpointsB D Lovett, D Strumberg, I A Blair, et al.
Pageof 28